Quantumzyme Corp. (OTC: QTZM), a biotransformation company specializing in enzyme-based solutions for pharmaceutical manufacturing, today announced that it plans to attend the 2026 BIO International Convention, to be held June 22–25, 2026, in San Diego, California. The company’s attendance is limited to observation and informal networking, with no plans for presenting, exhibiting, or sponsoring at the event.
The BIO International Convention is a global gathering of biotechnology and life sciences companies, academic institutions, and industry participants. For Quantumzyme, the convention represents a key opportunity to engage with peers across the biotechnology and biomanufacturing ecosystem. “We view the BIO International Convention as an important opportunity to connect with peers across the biotechnology and biomanufacturing ecosystem,” said Naveen Kulkarni, Chief Executive Officer of Quantumzyme Corp. “Our attendance is focused on listening, learning, and engaging in informal discussions with industry participants as we continue to evaluate developments relevant to our technology and long-term objectives.”
Quantumzyme’s participation is part of its ongoing efforts to increase industry awareness and maintain dialogue with potential collaborators, technology partners, and other stakeholders. However, the company cautioned that there can be no assurance that discussions initiated during the conference will result in any agreements, transactions, or future business relationships. This measured approach reflects Quantumzyme’s strategic focus on evaluating the landscape before committing to formal partnerships.
The company’s technology centers on sustainable enzyme-based solutions for pharmaceutical manufacturing, applying quantum mechanics, molecular modeling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts. These efforts aim to enhance efficiency, reduce waste, and support environmentally responsible production. By integrating computational modeling with laboratory validation, Quantumzyme seeks to deliver scalable, cost-effective biocatalysis solutions.
Additional information regarding the BIO International Convention is available at https://convention.bio.org. For more information and updates, visit www.quantumzymecorp.com and the Company’s profile at www.otcmarkets.com/stock/QTZM.
